Clinical trials
Bipolar Disorder I or II clinical trials
Below are recruiting bipolar disorder i or ii clinical trials, each written for real people, not researchers. We’re tracking 2,350 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07819773Recruiting
Device for treating generalized anxiety
This study tests a device that uses magnetic pulses to stimulate the brain, which may help reduce symptoms of generalized anxiety disorder (GAD). The treatment is non-invasive and does not require surgery.
Denver, ColoradoAges 22 years+ - NCT06477991Recruiting
No surgery after immunotherapy for MSI-H colorectal cancer
This trial is studying whether some people with a specific type of advanced colorectal cancer (MSI-H/dMMR) might be able to skip surgery after immunotherapy. Doctors will use a blood test (MRD monitoring) to track the cancer, and then decide whether to keep an eye on it or operate.
Kunming, YunnanAges 18–75 - NCT07818876Recruiting
Computer training to help teens with anxiety
This study tests a computer-based training program that aims to change how anxious teens interpret situations. It could help reduce anxiety by retraining the brain's automatic responses.
Denver, ColoradoAges 10–17 - NCT07817589Recruiting
Adding yoga to exercise rehab for heart failure
This study tests whether adding yoga to a hospital-based cardiac rehabilitation program can improve the health and well-being of people with heart failure. It might help you feel better and manage your condition more effectively.
Dharwad, KarnatakaAges 18 years+ - NCT07818668Recruiting
Brain stimulation for self-other boundaries in schizophrenia
This study tests a gentle brain stimulation method called transcranial alternating current stimulation (tACS) to see if it can help people with schizophrenia better tell the difference between themselves and others, which may reduce symptoms like hallucinations and delusions.
Hefei, AnhuiAges 18–50 - NCT07819448Recruiting
Aerobic exercise added to depression treatment
This study tests whether adding aerobic exercise (like walking, jogging, or cycling) to your usual depression treatment helps improve your mood. It is for adults with moderate or severe depression who are not already exercising regularly.
Chak Four Hundred Fifty-four, Punjab ProvinceAges 18–55 - NCT05866575Recruiting
Brain-modeling trial to predict depression treatment response
This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.
La Tronche, IsèreAges 18 years+ - NCT07815691RecruitingPhase 2
Cannabis and the brain reward system study
This study looks at how cannabis affects your brain's reward system using MRI scans. It aims to understand why some people develop cannabis use disorder, which may lead to better treatments.
Charleston, South CarolinaAges 21–45 - NCT07815223RecruitingPhase 2
Immunotherapy and targeted drug after chemoradiation for limited-stage small cell lung cancer
This trial tests whether adding two medications—tislelizumab (an immunotherapy that helps your immune system fight cancer) and anlotinib (a targeted drug that blocks blood supply to tumors)—after standard chemoradiation can help keep limited-stage small cell lung cancer from coming back. It may offer a new option to improve outcomes for patients who have already responded to initial treatment.
Yantai, ShandongAges 18–75 - NCT07817082RecruitingPhase 2
A new drug for her2 ultra-low advanced breast cancer
This study tests a new targeted drug (SHR-A1811) for breast cancer that has very low HER2 levels. The drug is designed to attack cancer cells with this specific marker, and the study aims to see if it can help slow the cancer's growth.
TianjinAges 18–75 - NCT07810023Enrolling by invitation
Ketamine shot for suicidal distress in the emergency room
This study tests whether a single ketamine injection can quickly reduce suicidal thoughts in people waiting to be admitted to the psychiatric unit. Ketamine is a fast-acting medication that may help calm the mind during a crisis.
Evanston, IllinoisAges 18 years+ - NCT07813962Recruiting
Reducing PTSD risk after trauma surgery
This study tests whether a sedative medication (dexmedetomidine) plus a gentle electrical stimulation on the ear can lower the chance of developing post-traumatic stress disorder (PTSD) after emergency surgery for a serious injury. If you qualify, you will receive this treatment during your operation and be checked for PTSD symptoms for one month afterward.
Nantong, JiangsuAges 18–80 - NCT07812753Recruiting
Brain stimulation for smoking cessation
This study looks at how a non-invasive brain stimulation technique called TMS (which uses magnetic pulses to stimulate the brain) might affect the brain's reward system in people who smoke. The goal is to understand how to help people quit smoking more effectively.
Newark, New JerseyAges 18–60 - NCT07814027Recruiting
Trial comparing two surgeries for achalasia
This trial compares two surgeries to treat achalasia, a condition where the esophagus fails to push food into the stomach. Both procedures aim to relax the muscle at the bottom of the esophagus, and the study will see which one works better for improving your symptoms.
Minya, Minya GovernorateAges 18–75 - NCT06474819Recruiting
Comparing two pacemaker lead placements to protect heart function
This study compares two ways of placing a pacemaker lead to see if one protects your heart's pumping ability better over time. It may help prevent heart muscle weakness caused by pacing.
BarcelonaAges 18 years+ - NCT06506292RecruitingPhase 2
Study of adebrelimab plus chemo before and after stomach cancer surgery
This trial tests combining adebrelimab (an immunotherapy) with chemotherapy (XELOX) before and after surgery for stomach cancer that hasn't spread. The goal is to see if this approach helps shrink tumors and improves outcomes.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07806292RecruitingPhase 2
Combination therapy for inoperable liver cancer
This study tests a combination of two drugs (anlotinib and benmelstobart) with a liver-directed chemotherapy procedure (HAIC) in people with liver cancer that cannot be removed surgically. The goal is to see if this combo shrinks tumors and is safe.
Guangzhou, GuangdongAges 18–75 - NCT07808853RecruitingPhase 2
Short radiation plus chemo-immunotherapy before esophageal cancer surgery
This trial tests a new approach before surgery: a short course of radiation (5 treatments) combined with chemotherapy and immunotherapy. The goal is to shrink the tumor and increase the chance of successful removal, while hopefully reducing side effects and improving long-term outcomes.
Guanzhou, GuangdongAges 18–75 - NCT07806383Enrolling by invitation
Effects of a sugar-based supplement on heart and gut health in overweight adults
This study tests a sugar-based supplement (a synbiotic) to see if it improves heart and metabolic health markers as well as gut health in people who are overweight but otherwise healthy. You will take the supplement for a period of time, and your health will be monitored.
NaplesAges 20–70 - NCT04837859RecruitingPhase 2
Personalized immunotherapy for early-stage unfavorable Hodgkin lymphoma
This trial studies a customized immune-based treatment approach for people with early-stage “unfavorable” classical Hodgkin lymphoma who have not had prior treatment. It may help by targeting your lymphoma using an individualized plan based on your case.
CologneAges 18 years+ - NCT07794813Recruiting
Imaging agent for clearer tumor removal in oral cancer surgery
This study tests a new imaging agent that helps surgeons see oral tumors more clearly during surgery. It aims to improve the accuracy of tumor removal.
Kunming, YunnanAges 18–75 - NCT07795749RecruitingPhase 2
Intraperitoneal paclitaxel with systemic therapy for gastrointestinal cancer with peritoneal spread
This study tests a treatment that combines chemotherapy given directly into the abdomen (intraperitoneal) with standard systemic chemotherapy for people whose gastrointestinal cancer has spread to the lining of the abdomen (peritoneal carcinomatosis). It aims to control the cancer and improve how patients feel.
Orange, CaliforniaAges 18 years+ - NCT07797816RecruitingPhase 2
Targeted drug combo with radiation for advanced bile duct cancer
This trial tests a combination of two chemotherapy drugs and an immunotherapy drug, followed by targeted radiation, in people with bile duct or gallbladder cancer that cannot be removed with surgery. The goal is to see if this approach can shrink tumors and improve outcomes.
Nanjing, JiangsuAges 18–80 - NCT07798297Recruiting
Sound sensitivity therapy for autistic adults
This trial tests a therapy designed to help autistic adults who are very sensitive to everyday sounds. The treatment aims to make loud sounds more comfortable and improve daily life.
Orlando, FloridaAges 18–39
Hear when a new Bipolar Disorder I or II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bipolar disorder i or ii?
- Yes. Clin2 currently lists 2,350 recruiting bipolar disorder i or ii studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bipolar disorder i or ii trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bipolar disorder i or ii trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.